X0306 4 2017-11-10 0 0001492658 Wright Medical Group N.V. WMGI 0001329922 Morrison Gregory 1023 CHERRY ROAD MEMPHIS TN 38117 0 1 0 0 SVP, Human Resources Ordinary Shares, par value EUR 0.03 per share 2017-11-10 4 M 0 10899 21.24 A 88387 D Ordinary Shares, par value EUR 0.03 per share 2017-11-10 4 M 0 39241 20.62 A 127628 D Ordinary Shares, par value EUR 0.03 per share 2017-11-10 4 S 0 50140 23.7419 D 77488 D Ordinary Shares, par value EUR 0.03 per share 2017-11-13 4 S 0 42000 23.6453 D 35488 D Stock Option (right to buy) 21.24 2017-11-10 4 M 0 10899 21.24 D 2026-07-19 Ordinary Shares 10899 23991 D Stock Option (right to buy) 20.62 2017-11-10 4 M 0 39241 20.62 D 2025-10-13 Ordinary Shares 39241 39307 D Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.62 to $24.02, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.51 to $23.82, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. This option vested with respect to 25% of the shares on October 13, 2016 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. /s/ Marija Nelson, attorney-in-fact 2017-11-14